135 related articles for article (PubMed ID: 19718248)
1. Effective monotherapy with amrubicin for a refractory extrapulmonary small-cell carcinoma of the liver.
Isobe T; Yanai S; Kusaba H; Yada S; Kuroda Y; Tamiya S; Matsumoto T; Baba E; Harada M
Case Rep Med; 2009; 2009():538081. PubMed ID: 19718248
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status.
Igawa S; Shirasawa M; Fukui T; Nishinarita N; Sone H; Ozawa T; Sugita K; Okuma Y; Kurahayashi S; Ono T; Sugimoto A; Mitsufuji H; Kubota M; Katagiri M; Sasaki J; Naoki K
Oncology; 2018; 94(4):207-214. PubMed ID: 29393275
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of sequential triplet chemotherapy, irinotecan and cisplatin followed by amrubicin, in patients with extensive-stage small cell lung cancer: West Japan Thoracic Oncology Group Study 0301.
Kobayashi M; Matsui K; Iwamoto Y; Ebi N; Oizumi S; Takeda K; Sawa T; Shibata K; Saka H; Imamura F; Seki N; Saito H; Goto I; Nakagawa K;
J Thorac Oncol; 2010 Jul; 5(7):1075-80. PubMed ID: 20479694
[TBL] [Abstract][Full Text] [Related]
4. Amrubicin Monotherapy for Patients with Platinum-Refractory Gastroenteropancreatic Neuroendocrine Carcinoma.
Ando T; Hosokawa A; Yoshita H; Ueda A; Kajiura S; Mihara H; Nanjo S; Fujinami H; Nishikawa J; Ogawa K; Nakajima T; Imura J; Sugiyama T
Gastroenterol Res Pract; 2015; 2015():425876. PubMed ID: 26199623
[TBL] [Abstract][Full Text] [Related]
5. Second-line chemotherapy for refractory small cell neuroendocrine carcinoma of the esophagus that relapsed after complete remission with irinotecan plus cisplatin therapy: Case report and review of the literature.
Funakoshi S; Hashiguchi A; Teramoto K; Miyata N; Kurita S; Adachi M; Hamamoto Y; Higuchi H; Takaishi H; Hibi T
Oncol Lett; 2013 Jan; 5(1):117-122. PubMed ID: 23255905
[TBL] [Abstract][Full Text] [Related]
6. Complete response of esophageal small cell carcinoma amrubicin treatment.
Nagasaki E; Yuda M; Tanishima Y; Arakawa Y; Kobayashi K; Sakuyama T; Inoue D; Nishikawa K; Kobayashi M; Omura N; Kobayashi T; Aiba K
J Infect Chemother; 2013 Aug; 19(4):770-5. PubMed ID: 23160626
[TBL] [Abstract][Full Text] [Related]
7. Effective treatment of relapsed prostate small cell carcinoma with amrubicin: report of a case.
Kobayashi K; Muto M; Shigematsu Y
Int Cancer Conf J; 2020 Jul; 9(3):155-158. PubMed ID: 32582522
[TBL] [Abstract][Full Text] [Related]
8. Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer - EORTC 08062.
O'Brien ME; Konopa K; Lorigan P; Bosquee L; Marshall E; Bustin F; Margerit S; Fink C; Stigt JA; Dingemans AM; Hasan B; Van Meerbeeck J; Baas P
Eur J Cancer; 2011 Oct; 47(15):2322-30. PubMed ID: 21684151
[TBL] [Abstract][Full Text] [Related]
9. Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.
Hirai F; Seto T; Yamanaka T; Toyozawa R; Inamasu E; Kojo M; Toyokawa G; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
Jpn J Clin Oncol; 2013 Oct; 43(10):1018-22. PubMed ID: 23917962
[TBL] [Abstract][Full Text] [Related]
10. [METASTATIC SMALL CELL CARCINOMA OF THE URINARY BLADDER TREATED WITH SYSTEMIC CHEMOTHERAPY INCLUDING AN AMRUBICIN; A CASE REPORT].
Naito A; Matsumoto A; Odani K; Sato Y; Azuma T; Ishizawa M; Nagase Y; Oshi M; Homma Y
Nihon Hinyokika Gakkai Zasshi; 2016; 107(1):34-38. PubMed ID: 28132989
[TBL] [Abstract][Full Text] [Related]
11. Metastatic small cell bladder cancer treated with sequential systemic therapy including pembrolizumab and amrubicin: A case report.
Mitani K; Tsuboi I; Tanaka G; Yosioka S; Yokoyama S; Kobayashi Y; Nakajima H; Nagami T; Ogawa K; Wada K
IJU Case Rep; 2024 Mar; 7(2):127-130. PubMed ID: 38440697
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.
Okuma HS; Horinouchi H; Kitahara S; Asao T; Sunami K; Goto Y; Kanda S; Fujiwara Y; Nokihara H; Yamamoto N; Ohe Y
Clin Lung Cancer; 2017 Mar; 18(2):234-240.e2. PubMed ID: 27867001
[TBL] [Abstract][Full Text] [Related]
13. Amrubicin is effective against small cell carcinoma of the prostate as a second-line chemotherapeutic agent: A case report.
Maesaka F; Nakai Y; Tomizawa M; Owari T; Miyake M; Inoue T; Anai S; Tanaka N; Fujimoto K
IJU Case Rep; 2019 May; 2(3):133-136. PubMed ID: 32743393
[TBL] [Abstract][Full Text] [Related]
14. Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium.
Spigel DR; Hainsworth JD; Shipley DL; Mekhail TM; Zubkus JD; Waterhouse DM; Daniel DB; Burris HA; Greco FA
Lung Cancer; 2018 Mar; 117():38-43. PubMed ID: 29496254
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors and response of chemotherapy including amrubicin in small cell lung cancer patients].
Wang Y; Liu L; Wu M; Zhong J; Liu X; An T; Zhao J; Duan J; Wang Z; Zhou M; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2015 Apr; 38(4):261-6. PubMed ID: 26268231
[TBL] [Abstract][Full Text] [Related]
16. A randomized phase III study of single-agent amrubicin vs. carboplatin/etoposide in elderly patients with extensive-disease small-cell lung cancer.
Sekine I; Okamoto H; Horai T; Nakagawa K; Ohmatsu H; Yokoyama A; Katakami N; Shibuya M; Saijo N; Fukuoka M
Clin Lung Cancer; 2014 Mar; 15(2):96-102. PubMed ID: 24361248
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer.
Sun Y; Cheng Y; Hao X; Wang J; Hu C; Han B; Liu X; Zhang L; Wan H; Xia Z; Liu Y; Li W; Hou M; Zhang H; Xiu Q; Zhu Y; Feng J; Qin S; Luo X
BMC Cancer; 2016 Apr; 16():265. PubMed ID: 27061082
[TBL] [Abstract][Full Text] [Related]
18. Recurrent pulmonary synovial sarcoma effectively treated with amrubicin: A case report.
Satoh H; Takayashiki N; Shiozawa T; Miyazaki K; Ohara G; Kagohashi K; Kurishima K; Sugita S; Aoyama T; Hasegawa T; Hizawa N
Exp Ther Med; 2015 May; 9(5):1947-1949. PubMed ID: 26136920
[TBL] [Abstract][Full Text] [Related]
19. [A case of relapsed small-cell lung cancer successfully treated by administration of amrubicin].
Mori H; Tanaka H
Nihon Kokyuki Gakkai Zasshi; 2007 Dec; 45(12):967-70. PubMed ID: 18186244
[TBL] [Abstract][Full Text] [Related]
20. Amrubicin for non-small-cell lung cancer and small-cell lung cancer.
Kurata T; Okamoto I; Tamura K; Fukuoka M
Invest New Drugs; 2007 Oct; 25(5):499-504. PubMed ID: 17628745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
